Rock Springs Capital Management LP Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001595725

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidHealth TiltHigh Turnover how tags are computed

Q3 2026 · 105 positions · Total reported value $1.85B · Top-10 concentration 43.2% · Updated 2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

Turnover: 39.8% · 9 new · 28 cut · 8 exited

Active Share (vs S&P 500): 96.8% · vs QQQ: 99.2% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -7.5% · vs SPY -9.6% · Prev Value $2.05B — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -2.4% · vs SPY -4.5% · Latest Value $1.85B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q3 2026 13F filing, Rock Springs Capital Management LP disclosed 105 equity positions with a combined reported value of $1.85B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 43.2% of reported value. HoldingsHub classifies the profile as Mid / Health Tilt / High Turnover.

The largest disclosed positions as of Q3 2026 were RVMD ($178.42M), TVTX ($129.78M), LLY ($114.20M). By sector, the heaviest allocations are Health Care 96.9%, Industrials 1.3%.

Versus the prior quarter, Rock Springs Capital Management LP opened 9 new positions, trimmed 28 and fully exited 8, a turnover rate of 39.8% of positions. The portfolio's overlap with the prior quarter was 85% of names.

The largest new positions opened in Q3 2026 were ARTV ($10.93M), ABCL ($4.01M), IONS ($2.92M).

Of the 8 positions fully exited versus the prior quarter, the largest were MDT ($2.42M), DNTH ($1.98M), ALT ($1.43M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q3 2026)

  • ARTV LATIGO BIOTHERAPEUTICS INC · $10.93M
  • ABCL ABCELLERA BIOLOGICS INC · $4.01M
  • IONS IONIS PHARMACEUTICALS INC · $2.92M
  • IMVT IMMUNOVANT INC · $2.37M
  • AVIR ATEA PHARMACEUTICALS INC · $2.26M
  • CELC CELCUITY INC · $2.03M
  • CLYM CLIMB BIO INC · $1.34M
  • HUM HUMANA INC · $1.28M

Fully Exited (vs previous quarter)

  • MDT MEDTRONIC PLC · prev qtr: $2.42M
  • DNTH DIANTHUS THERAPEUTICS INC · prev qtr: $1.98M
  • ALT ALTIMMUNE INC · prev qtr: $1.43M
  • SGRY SURGERY PARTNERS INC · prev qtr: $1.41M
  • ORKA ORUKA THERAPEUTICS INC · prev qtr: $1.15M
  • VKTX VIKING THERAPEUTICS INC · prev qtr: $994.75K
  • GKOS GLAUKOS CORP · prev qtr: $663.86K
  • MLTX MOONLAKE IMMUNOTHERAPEUTICS · prev qtr: $208.25K

Insider Transactions (Form 4)

Latest Rock Springs Capital Management LP buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Rock Springs Capital Management LP is an SEC-registered 13F filer based in Baltimore, MD, United States. As of Q2 2026 it reported 104 US equity positions with a combined value of $2.05B. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: BALTIMORE, MD, United States
  • SEC registration: 801-78511 (status: Approved), registered 2013-09-27
  • Regulatory AUM (Form ADV): $2.43B as of 2026-03-24
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 2 private funds, of which 2 hedge funds

Portfolio Structure

  • 104 positions · $2.05B reported value (Q2 2026)
  • Top 10 holdings = 44.0% of reported value
  • Largest position: RVMD (REVOLUTION MEDICINES INC) at 10.1%
  • Average position size: $19.70M

Sector Tilt

  • Health Care 96.8%
  • Industrials 1.1%
  • Consumer Discretionary 1.0%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q2 2026: 16 new, 35 added, 31 reduced, 12 exited
  • 22 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

AI Rebalance Analysis

1. Overall direction and market view: The fund reduced exposure to biotech/clinical-stage names (RVMD, MIRM, KYMR, SRRK) while adding to established pharma (LLY, MDGL) and healthcare services (UNH), suggesting a cautious shift toward more stable, cash-generative healthcare assets amid volatility. 2. Key moves: - Reduced: RVMD (shares -21.3%), MIRM (-2.3%), KYMR (-9.6%), SRRK (-4.6%). - Added: TVTX (+1.1%), MDGL (+1.3%), INSM (+0.9%), UNH (+44.7%). 3. Portfolio structure: Active, concentrated (105 positions), with heavy Health Care bias (>90%). Focuses on high-growth biotech but trims speculative names, indicating moderate risk appetite. 4. Per-holding one-liner: - RVMD: Revolution Medicines (unverified), biotech. - TVTX: Traverze Therapeutics (unverified), biotech. - LLY: Eli Lilly, established pharma. - MDGL: Madrigal Pharmaceuticals (unverified), biotech. - MIRM: Mirum Pharmaceuticals (unverified), biotech. - RYTM: Rhythm Pharmaceuticals (unverified), biotech. - KYMR: Kymera Therapeutics (unverified), biotech. - INSM: Insmed, biotech. - UNH: UnitedHealth, healthcare services. - SRRK: Scholar Rock (unverified), biotech. 5. Style summary: Rotating from volatile clinical-stage biotech toward established pharma and healthcare services, trimming losers while adding select names.

Generated by GLM-4.5-flash from the latest 13F holdings and quarter-over-quarter changes. For reference only, not investment advice. · AI generated 2026-11-17 04:25

Sector Allocation

Health Care 96.9%
Technology 0.4%
Other 0.4%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 869.26K $178.42M 9.65%
9.65%
Reduce
2 2.20M $129.78M 7.02%
7.02%
Add
3 98.70K $114.20M 6.18%
6.18%
Hold
4 177.25K $89.33M 4.83%
4.83%
Add
5 779.79K $66.66M 3.61%
3.61%
Reduce
6 692.60K $65.95M 3.57%
3.57%
Hold
7 409.63K $45.79M 2.48%
2.48%
Reduce
8 365.25K $41.69M 2.26%
2.26%
Add
9 92.25K $33.86M 1.83%
1.83%
Add
10 682.65K $32.99M 1.78%
1.78%
Reduce
11 144.00K $32.81M 1.77%
1.77%
Reduce
12 125.00K $31.95M 1.73%
1.73%
Hold
13 1.60M $31.25M 1.69%
1.69%
Add
14 273.95K $31.14M 1.69%
1.69%
Add
15 72.25K $29.38M 1.59%
1.59%
Reduce
16 30.00K $28.77M 1.56%
1.56%
Reduce
17 575.00K $28.61M 1.55%
1.55%
Hold
18 293.50K $25.33M 1.37%
1.37%
Reduce
19 535.00K $23.35M 1.26%
1.26%
Add
20 285.12K $22.41M 1.21%
1.21%
Add
21 756.77K $22.02M 1.19%
1.19%
Add
22 653.34K $21.17M 1.15%
1.15%
Reduce
23 262.50K $20.89M 1.13%
1.13%
Hold
24 791.31K $20.84M 1.13%
1.13%
Reduce
25 1.41M $20.60M 1.11%
1.11%
Hold
26 648.33K $20.57M 1.11%
1.11%
Hold
27 640.32K $20.02M 1.08%
1.08%
Hold
28 3.79M $19.94M 1.08%
1.08%
Reduce
29 524.76K $19.52M 1.06%
1.06%
Reduce
30 60.00K $19.10M 1.03%
1.03%
Reduce
31 662.92K $18.89M 1.02%
1.02%
Hold
32 577.28K $18.64M 1.01%
1.01%
Hold
33 130.50K $18.51M 1.00%
1.00%
Reduce
34 393.66K $18.05M 0.98%
0.98%
Reduce
35 575.43K $17.75M 0.96%
0.96%
Hold
36 244.00K $16.92M 0.92%
0.92%
Hold
37 76.30K $16.90M 0.92%
0.92%
Hold
38 275.35K $16.14M 0.87%
0.87%
Reduce
39 847.21K $16.13M 0.87%
0.87%
Add
40 472.33K $15.71M 0.85%
0.85%
Reduce
41 613.94K $14.93M 0.81%
0.81%
Add
42 891.87K $14.37M 0.78%
0.78%
Reduce
43 925.09K $13.90M 0.75%
0.75%
Reduce
44 502.08K $13.54M 0.73%
0.73%
Hold
45 438.50K $13.43M 0.73%
0.73%
Reduce
46 201.84K $13.30M 0.72%
0.72%
Add
47 192.25K $12.65M 0.69%
0.69%
Add
48 389.36K $12.47M 0.68%
0.68%
Reduce
49 484.95K $12.19M 0.66%
0.66%
Hold
50 715.00K $12.09M 0.65%
0.65%
Hold

FAQ

What did Rock Springs Capital Management LP buy in 2026-Q3?

In its 2026-Q3 13F filing, Rock Springs Capital Management LP reported 105 equity positions worth $1.85B in aggregate; its largest disclosed positions were RVMD ($178.42M), TVTX ($129.78M), LLY ($114.20M).

How large is Rock Springs Capital Management LP's portfolio?

Rock Springs Capital Management LP reported $1.85B of long equity holdings across 105 positions as of 2026-Q3. Top-10 holdings account for 43.2% of reported value.

What is Rock Springs Capital Management LP's investment style?

HoldingsHub classifies the portfolio as Mid / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/rock-springs-capital-management/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →